Ovarian Cysts Clinical Trial
Official title:
Laparoscopy-assisted Ovarian Cystectomy: NEW APPROCH
NCT number | NCT03370952 |
Other study ID # | 15 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | December 21, 2017 |
Est. completion date | August 3, 2019 |
Verified date | January 2022 |
Source | Cairo University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Under general anaesthesia, the patient is placed in the modified dorsal lithotomy position a 10-mm umbilical trocar is inserted. A panoramic view of the pelvis was obtained together with full assessment of the ovarian mass(es). Aspiration of the cyst: Veress needle is inserted in the midline 2 cm above the symphysis pubis to aspirate the cyst under laparoscopic guidance (to guide the entry of the needle into the cyst wall & to confirm complete aspiration). Delivery of affected ovary outside the abdominal cavity: Classic ovarian cystectomy will be done using microsurgical techniques in which the cyst wall will be dissected gently and carefully from the healthy ovarian tissue followed by perfect haemostasis and re-fashioning of the remaining ovarian tissue using Vicryl (3-0) sutures. Re-introduction of the ovary to inside the abdominal cavity: The stitched ovary is pushed gently inside the abdominal cavity and the mini-laparotomy is re-covered by the rubber shield (to allow re-inflation of the abdominal cavity). The ovary is reassessed under laparoscopic guidance to ensure perfect haemostasis and normal position of the ovary. Pelvic irrigation is done if needed.
Status | Completed |
Enrollment | 112 |
Est. completion date | August 3, 2019 |
Est. primary completion date | July 5, 2019 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 35 Years |
Eligibility | Inclusion Criteria: - unilateral or bilateral ovarian cysts (= 10 cm), - recurrent ovarian cysts - good ovarian reserve (antimullerian hormone {AMH} > 1 ng/ml & antral follicular count {AFC} > 4) Exclusion Criteria: - solid ovarian masses - patients who were unfit for surgery - chronic diseases (e.g. cardiac disease or diabetes) - any contraindication for laparoscopic surgery (excessive anterior abdominal wall scarring) |
Country | Name | City | State |
---|---|---|---|
Egypt | Kasr Alainy medical school | Cairo |
Lead Sponsor | Collaborator |
---|---|
Cairo University |
Egypt,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | recurrence of ovarian masses | recurrence was defined as the presence of ovarian cysts =2 cm in the ipsilateral ovary | 6 months after the operation | |
Secondary | serum follicle stimulating hormone | Measurement of FSH on 2nd day of a natural cycle as a marker of ovarian reserve | 6 months after the operation | |
Secondary | Serum antimullerian hormone | Measurement of AMH on 2nd day of a natural cycle as a marker of ovarian reserve | 6 months after the operation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02890914 -
Transvaginal Ultrasound Training for Obstetrics and Gynecology Residents
|
N/A | |
Completed |
NCT01779232 -
Danazol Treatment in Endometriosis Women Before IVF
|
Phase 4 | |
Completed |
NCT05054946 -
The Effect of Laparoscopic Surgery on Ovarian Reserve According to Cyst Types
|
N/A | |
Completed |
NCT02852447 -
The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve
|
N/A | |
Completed |
NCT00713778 -
The Impact of Electrocoagulation on Ovarian Reserve After Laparoscopic Excision of Ovarian Cyst
|
Phase 4 | |
Suspended |
NCT00865488 -
Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery
|
Phase 3 | |
Completed |
NCT04142203 -
Implementation of 23 Hour Surgery Model in a Tertiary Hospital
|
||
Recruiting |
NCT05842629 -
Improved Diagnosis of Ovarian Cancer
|
||
Completed |
NCT05376384 -
Ovarian Cyst's Enucleation Spillage Score
|
||
Recruiting |
NCT04993924 -
GnRH Antagonist Pre-treatment in the Early Follicular Phase for Resolution of a Baseline Functional Ovarian Cyst
|
Phase 4 | |
Terminated |
NCT03189316 -
Anti-inflammatory Cells in Peritoneal Cavity
|
N/A | |
Completed |
NCT05800613 -
Management of Ovarian Masses in Pediatric Patients: an Italian Survey
|
||
Completed |
NCT04355312 -
Using INDOcyanine Green to Analyse Ovarian Vascularization After Ovarian Laparoscopic CYStectomy
|
N/A | |
Completed |
NCT05418595 -
Ultrasonographic Evaluation of Ovarian Stromal Vascularity in Women With Polycystic Ovary Syndrome (PCOS)
|
||
Completed |
NCT06342934 -
Radiomics and Machine Learning in the Diagnosis of Ovarian Masses
|
||
Completed |
NCT06227676 -
Effect of 'Cramp Bites' on Period Cramps in Women Aged 18-25
|
Phase 2/Phase 3 | |
Completed |
NCT02831556 -
Point of Care 3D Ultrasound for Various Applications: A Pilot Study
|
||
Recruiting |
NCT05763511 -
Improved Diagnosis of Ovarian Cancer by Use of Circulating Tumor DNA as a Biomarker
|
||
Completed |
NCT06064331 -
Effect of Intravenous Lignocaine Infusion on Intraoperative End Tidal Desflurane Concentration Requirements
|
N/A | |
Recruiting |
NCT02086318 -
A New Algorithm to Predict Ovarian Age
|
N/A |